your search: Result
Relevance of hit 2% back to search result index | New search

[51] Information by division/country and region Audited

XLS

Information by division

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Merck Serono

Consumer Health

Performance Materials

€ million

2013

2012

2013

2012

2013

2012

1

Previous year’s figures have been adjusted, see Note [52]

2

According to the cash flow statement

Sales

5,953.6

5,995.8

476.9

472.6

1,642.1

1,674.2

Royalty, license and commission income

372.2

409.4

2.7

2.6

2.3

1.4

Total revenues

6,325.8

6,405.2

479.6

475.2

1,644.4

1,675.6

Gross margin

5,219.7

5,212.1

318.3

316.7

1,028.5

959.1

Marketing and selling expenses

–1,288.7

–1,370.8

–213.0

–218.5

–140.5

–142.8

Royalty, license and commission expenses

–547.7

–561.6

–2.0

–1.0

–1.3

–1.5

Administration expenses1

–211.3

–216.8

–18.1

–19.9

–27.8

–31.2

Other operating expenses and income1

–499.4

–669.0

–3.5

–46.2

–47.9

–32.0

Research and development

–1,182.8

–1,187.3

–17.1

–19.4

–143.0

–137.4

Operating result (EBIT)1

893.0

547.7

62.2

7.6

653.3

609.7

Depreciation and amortization

797.4

881.1

8.6

11.5

107.7

114.1

Impairment losses

196.4

51.2

0.3

10.7

9.3

12.1

Reversals of impairment losses

–0.3

–4.5

–1.3

EBITDA1

1,886.5

1,480.0

71.1

29.8

765.8

734.6

One-time items

68.5

344.7

1.4

37.0

13.9

7.3

EBITDA pre one-time items (segment result)1

1,955.0

1,824.7

72.5

66.8

779.7

741.9

EBITDA margin pre one-time items (in % of sales)1

32.8

30.4

15.2

14.1

47.5

44.3

Net operating assets

6,968.0

8,020.6

258.2

283.8

1,044.7

1,187.7

Segment liabilities

–1,358.0

–1,349.8

–74.5

–76.5

–155.9

–147.1

Investments in property, plant and equipment2

151.3

146.9

3.7

4.0

66.5

55.7

Investments in intangible assets2

80.6

88.7

0.4

0.4

6.7

28.6

Net cash flows from operating activities1

1,818.9

2,255.6

67.1

75.6

828.4

886.6

Business free cash flow1

1,875.7

1,880.2

83.9

88.8

787.8

798.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Merck Millipore

Corporate and Other

Group

€ million

2013

2012

2013

2012

2013

2012

Sales

2,627.5

2,598.2

10,700.1

10,740.8

Royalty, license and commission income

17.8

18.7

395.0

432.1

Total revenues

2,645.3

2,616.9

11,095.1

11,172.9

Gross margin

1,541.0

1,531.1

–4.9

–3.8

8,102.6

8,015.2

Marketing and selling expenses

–683.3

–675.7

–1.0

–3.0

–2,326.5

–2,410.8

Royalty, license and commission expenses

–16.1

–15.7

0.1

–567.0

–579.8

Administration expenses1

–99.2

–101.3

–206.0

–183.0

–562.4

–552.2

Other operating expenses and income1

–120.7

–116.5

–46.6

–262.2

–718.1

–1,125.9

Research and development

–159.8

–166.1

–1.6

–1.1

–1,504.3

–1,511.3

Operating result (EBIT)1

262.0

251.7

–259.7

–453.1

1,610.8

963.6

Depreciation and amortization

309.2

305.0

15.0

7.6

1,237.9

1,319.3

Impairment losses

18.8

4.2

0.8

0.5

225.6

78.7

Reversals of impairment losses

–0.2

–0.1

–0.1

–5.1

–1.4

EBITDA1

589.8

560.9

–244.0

–445.1

3,069.2

2,360.2

One-time items

53.0

53.5

47.3

162.2

184.1

604.7

EBITDA pre one-time items (segment result)1

642.8

614.4

–196.7

–282.9

3,253.3

2,964.9

EBITDA margin pre one-time items (in % of sales)1

24.5

23.6

30.4

27.6

Net operating assets

5,987.1

6,328.9

36.0

25.1

14,294.0

15,846.1

Segment liabilities

–391.9

–383.1

–64.8

–33.7

–2,045.1

–1,990.2

Investments in property, plant and equipment2

112.6

113.2

72.9

9.3

407.0

329.1

Investments in intangible assets2

10.3

10.0

11.6

16.5

109.6

144.2

Net cash flows from operating activities1

557.5

658.2

–1,046.4

–1,403.8

2,225.5

2,472.2

Business free cash flow1

493.8

511.3

–281.2

–309.1

2,960.0

2,969.3

XLS

Information by country and region

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Europe

thereof Germany

thereof France

€ million

2013

2012

2013

2012

2013

2012

Sales by customer location

3,984.6

3,942.7

825.4

801.5

677.0

696.0

Sales by company location

4,457.5

4,379.9

1,570.8

1,452.9

790.8

814.9

Total revenues

4,686.6

4,677.0

1,596.8

1,472.7

812.5

822.0

Intangible assets

7,572.4

8,293.4

398.0

344.9

278.0

302.1

Property, plant and equipment

2,075.2

2,344.3

997.5

996.4

183.6

173.9

Research and development

–1,357.4

–1,344.1

–849.0

–791.8

–56.4

–56.0

Number of employees

20,013

20,777

10,868

10,788

2,946

2,950

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

thereof Switzerland

North America

thereof USA

€ million

2013

2012

2013

2012

2013

2012

Sales by customer location

159.0

141.6

2,078.0

2,128.3

1,916.8

1,965.0

Sales by company location

188.6

174.2

2,072.7

2,121.4

1,933.1

1,979.0

Total revenues

364.5

438.4

2,077.1

2,122.1

1,937.5

1,979.7

Intangible assets

4,692.3

5,343.0

2,214.8

2,462.1

2,214.5

2,461.6

Property, plant and equipment

508.0

795.2

341.6

359.6

340.4

358.3

Research and development

–411.4

–462.1

–92.5

–114.5

–94.7

–113.3

Number of employees

1,232

1,926

4,911

4,848

4,754

4,688

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Emerging Markets

Rest of World

Group

€ million

2013

2012

2013

2012

2013

2012

Sales by customer location

3,795.6

3,712.2

841.9

957.6

10,700.1

10,740.8

Sales by company location

3,467.1

3,408.4

702.8

831.1

10,700.1

10,740.8

Total revenues

3,622.3

3,542.7

709.1

831.1

11,095.1

11,172.9

Intangible assets

46.5

141.3

33.5

47.7

9,867.2

10,944.5

Property, plant and equipment

169.3

163.7

61.1

86.0

2,647.2

2,953.6

Research and development

–36.6

–28.6

–17.8

–24.1

–1,504.3

–1,511.3

Number of employees

11,688

11,642

1,542

1,580

38,154

38,847